Journal News

Scientists sweep cellular neighborhoods where Zika hides out

Laurel Oldach
October 01, 2018

Most people infected with Zika never show symptoms. But the virus sometimes causes severe disability — from microcephaly in babies to weakness or partial paralysis in adults — and there is no treatment. In a paper in the journal Molecular & Cellular Proteomics, researchers report a comprehensive study of how the virus interacts with host cells. One of their findings gives insight into how Zika escapes immune signaling and proliferates inside the body.

This space-fill drawing shows the outside of one Zika virus particle (red and pink) and a cross-section through another as it interacts with a cell. Courtesy of David Goodsell/Wikimedia Commons

Like most viruses, Zika accomplishes a lot with a few tools. It has just one protein coding gene, which produces a single polypeptide that’s cleaved into 10 smaller proteins — a number dwarfed by the estimated 20,000 protein-coding genes in a human cell. Nevertheless, Zika can take over the vastly more complex human cell, repurposing it into a virus factory. Brian Raught, a researcher at the University of Toronto, said he found that process fascinating.

“With just these 10 proteins, this crazy virus turns your cells into zombies that do its bidding,” Raught said. “I always found that mind-blowing.”

Researchers in Raught’s lab, led by postdoctoral fellow Etienne Coyaud, wanted to find out how the handful of Zika proteins were able to hijack the host cell. They knew that the feat must depend on physical interactions between viral proteins and proteins native to the cell — but which ones?

Because of the increasing evidence linking Zika infections in expectant mothers to microcephaly in their children, Raught said, “We thought it better to leave the actual virus work to the experts.”

Instead of using infectious material, the team made 10 strains of human cells, each expressing one of Zika’s 10 proteins. By adding a small epitope tag to each viral protein, they were able to retrieve the viral proteins using an antibody that binds to this tag. The host proteins that stuck tightly to each viral protein came along for the ride; the researchers used mass spectrometry to identify those human proteins.

But there was a drawback to using this approach. What if proteins from the human cell were interacting with Zika proteins but separating from them before being extracted? To identify proteins that are close to but not inseparably intertwined with each viral protein, the team used a second technique called proximity labeling. In essence, they rigged each viral protein with an enzyme that would attach a sticky biotin tag onto anything that came close enough.

Proximity labeling is especially useful for detecting interactions with proteins embedded in cell membranes; those molecules are notoriously difficult to isolate.

“This is a really big asset of a proximity-labeling approach compared to traditional approaches,” Coyaud said.

Because Zika, like many viruses, enters the cell in a membrane-bound envelope and reorganizes many of its host’s membrane-bound organelles in the course of infection, its interactions with membrane proteins might be key to understanding the viral life cycle.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A novel technique maps antibodies’ epitope specificities
Journal News

A novel technique maps antibodies’ epitope specificities

January 06, 2021

Determining what proteins an antibody binds can be time and resource intensive. Researchers at Shanghai Jiao Tong University have developed a faster, less expensive approach to epitope mapping.

Cervical Health Awareness Month
Health Observance

Cervical Health Awareness Month

January 04, 2021

Cervical cancer is the most preventable cancer in women, yet more than 300,000 women worldwide lose their lives to it each year.

An immunologist answers three questions about COVID-19
News

An immunologist answers three questions about COVID-19

January 03, 2021

Should pregnant women get the COVID-19 vaccine? Will it protect against asymptomatic infections and mutated viruses?

‘Traffic jam’ discovery in yeast could lead to new disease treatments
Journal News

‘Traffic jam’ discovery in yeast could lead to new disease treatments

January 01, 2021

A Ball State University professor and students have identified two molecules they compare to tow trucks that help keep cells healthy.

New lipid class may shed light on causes of dental disease
Journal News

New lipid class may shed light on causes of dental disease

December 29, 2020

Researchers have made a discovery in mouth bacteria that might be linked via gut microbiota to disorders throughout the body.

From the journals: MCP
Journal News

From the journals: MCP

December 29, 2020

Protein profiles offer new insights into Duchenne muscular dystrophy. A novel fungal protease improves proteomic coverage. Expression of HLA-II shows promise for immunotherapy.